Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Financial Institutions
FISI
$825M
| $1.06M | ﹤0.01% |
41,378
-294
| -0.7% | -$7.34K |
|
3252
Fluence Energy
FLNC
$2.44B
| $1.06M | ﹤0.01% |
158,304
+72,866
| +85% | +$347K |
|
3253
Vanda Pharmaceuticals
VNDA
$314M
| $1.06M | ﹤0.01% |
224,404
+56,311
| +33% | +$246K |
|
3254
Tredegar Corp
TG
$281M
| $1.06M | ﹤0.01% |
120,165
+13,120
| +12% | +$106K |
|
3255
Red Violet
RDVT
$1.11B
| $1.05M | ﹤0.01% |
21,338
+7,261
| +52% | +$317K |
|
3256
National Presto Industries
NPK
$998M
| $1.05M | ﹤0.01% |
10,708
+2,994
| +39% | +$262K |
|
3257
Great Southern Bancorp
GSBC
$877M
| $1.05M | ﹤0.01% |
17,822
+5,318
| +43% | +$297K |
|
3258
Galicia Financial Group
GGAL
$7.23B
| $1.04M | ﹤0.01% |
20,730
+14,670
| +242% | +$840K |
|
3259
Celcuity
CELC
$4.49B
| $1.04M | ﹤0.01% |
78,076
+42,700
| +121% | +$465K |
|
|
TACO
3260
Berto Acquisition Corp
TACO
$392M
| $1.04M | ﹤0.01% |
+100,000
| New | +$1.04M |
|
3261
Taysha Gene Therapies
TSHA
$1.92B
| $1.04M | ﹤0.01% |
450,501
-258,465
| -36% | -$562K |
|
3262
Global Industrial
GIC
$1.49B
| $1.04M | ﹤0.01% |
38,507
+9,715
| +34% | +$244K |
|
3263
CALL
Frontier Group Holdings
ULCC
$1.54B
| $1.04M | ﹤0.01% |
+286,500
| New | +$1.05M |
|
3264
Brookfield Renewable
BEPC
$6.5B
| $1.04M | ﹤0.01% |
31,646
-20,262
| -39% | -$592K |
|
3265
BlackSky Technology
BKSY
$1.27B
| $1.04M | ﹤0.01% |
50,338
+24,356
| +94% | +$262K |
|
|
AVNS
3266
DELISTED
Avanos Medical
AVNS
| $1.03M | ﹤0.01% |
84,172
+25,459
| +43% | +$320K |
|
|
PKST
3267
DELISTED
Peakstone Realty Trust
PKST
| $1.03M | ﹤0.01% |
77,975
+40,611
| +109% | +$499K |
|
3268
Core Laboratories
CLB
$571M
| $1.03M | ﹤0.01% |
89,299
+25,125
| +39% | +$298K |
|
3269
Cass Information Systems
CASS
$750M
| $1.03M | ﹤0.01% |
23,676
+6,407
| +37% | +$268K |
|
3270
SmartFinancial
SMBK
$898M
| $1.03M | ﹤0.01% |
30,387
+9,967
| +49% | +$308K |
|
3271
Varex Imaging
VREX
$780M
| $1.03M | ﹤0.01% |
118,224
+29,612
| +33% | +$242K |
|
|
SNDK
3272
PUT
Sandisk
SNDK
$223B
| $1.02M | ﹤0.01% |
22,572
-8,250
| -27% | -$316K |
|
3273
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$12.1B
| $1.02M | ﹤0.01% |
43,010
| – | – |
|
3274
Invesco Mortgage Capital
IVR
$805M
| $1.02M | ﹤0.01% |
130,554
-200,062
| -61% | -$1.47M |
|
|
ORKA
3275
Oruka Therapeutics
ORKA
$7.16B
| $1.02M | ﹤0.01% |
91,164
+15,831
| +21% | +$165K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.